[ALNY] YoY Quarter Result on 31-Dec-2013 [#Q4]

Stock
[ALNY] Alnylam Pharmaceuticals, Inc.
Announcement Date
20-Feb-2014
Financial Year
2013
Quarter
31-Dec-2013 [#Q4]
Profit Trend
QoQ- -9.00%
YoY- 47.97%
Quarter Report
ALNY's Result
ALNY's Financial Summary
View:
Show?
Quarter Result
31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 CAGR
Revenue 17,454 7,551 24,019 10,847 8,495 20,455 21,192 -3.17%
PBT -112,934 -90,721 -43,480 -29,336 -72,760 -14,303 -6,503 60.85%
Tax -5,217 -6,685 -22,091 3,021 -10,572 -237 427 -
NP -112,934 -90,721 -21,389 -32,357 -62,188 -14,303 -6,930 59.15%
Tax Rate - - - - - - - -
Total Cost 130,388 98,272 45,408 43,204 70,683 34,758 28,122 29.10%
Ratio Analysis
31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 CAGR
NP Margin -647.04 -1,201.44 -89.05 -298.30 -732.05 -69.92 -32.70 64.38%
Per Share
31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 CAGR
EPS -1.32 -1.07 -0.28 -0.51 -1.20 -0.31 -0.16 42.10%
EPS Diluted -1.32 -1.07 -0.28 -0.51 -1.20 -0.31 -0.16 42.10%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.